PME 0.42% $134.24 pro medicus limited

There goes $50, page-18

  1. 459 Posts.
    lightbulb Created with Sketch. 15
    WOW breaking records here.
    article here.

    Pro Medicus share price on the moveInvestors remain confident in the Pro Medicus share price as the company continues to impress the market.

    During mid-May, Pro Medicus signed an 8-year contract to licence its Visage 7 Enterprise imaging platform to The University of Vermont Health Network Inc. This $14 million deal further cemented the company’s growth opportunities across the healthcare market in North America and other regions.

    Pro Medicus stated it’s won seven contracts in a row, building on its client base and revenue streams.In addition, the company also recently partnered with healthcare giant Mayo Clinic in a multi-year research agreement announced earlier this month. The framework is aimed at developing and commercialising artificial intelligence, leveraging Pro Medicus’ Visage AI Accelerator platform.

    The company believes the use of artificial intelligence will play an important role in the healthcare sector in the future. Its latest research collaboration is an integral part of the company’s AI strategy in meeting clinical goals with better patient outcomes
 
watchlist Created with Sketch. Add PME (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.